Published Jul 20, 2023
Drugging the Undruggable with Greg Verdine
Greg Verdine shares his journey from builder to pioneering chemist, exploring the art of drugging 'undruggable' targets and the crucial role of biotech startups in bridging biological discoveries and clinical interventions. This episode delves into the importance of unconventional thinking, mentorship, and strategic partnerships in driving scientific innovation.

Topics covered
Popular Clips
Episode Highlights
Related Episodes


Adapting Biopharma to AI with Greg Meyers
Answers 383 questions

Supercharging Discovery with Evan Feinberg
Answers 383 questions

Harnessing Water Dynamics for Drug Design with Michael Crackower and Jason Burch
Answers 383 questions

Drag & Drop Genome Editing
Answers 383 questions

The Power of Drug Discovery with Philip Tagari
Answers 383 questions

Adapting Biopharma to AI: A 2024 Update with Greg Meyers
Answers 383 questions

Biotech Revolution with Software Engineering Daily
Answers 383 questions

The Intersection of Biotech x High Tech with Vineeta Agarwala
Answers 383 questions

AI and Actionable Insights for Drug Development with Daphne Koller
Answers 383 questions

Adapting Biopharma to AI with Greg Meyers
Answers 383 questions

Protecting the Golden Age of Medicine with John Crowley
Answers 383 questions

Reengineering Healthcare and Medicine with Technology with Vineeta Agarwala
Answers 383 questions

Biology by Design
Answers 383 questions

From Surgeon to Biotech CEO with Jonathan Lim
Answers 383 questions
The Science and Supply of GLP-1s with Brooke Boyarsky Pratt
Answers 383 questions
